drugset / Trial / NCT03315975

Flu Vaccine Responses in the Setting of Melanoma Treatment

NCT03315975

Phase 4 Active not recruiting 40 enrolled University of Pennsylvania
NaSingle-groupOpen-labelBasic science

Summary

Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.

Timeline

Start
2017-10-20
Primary completion
2026-07-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intramuscular